Detalles de la búsqueda
1.
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUKfive).
Haematologica
; 106(10): 2694-2706, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910333
2.
Metronomic oral cyclophosphamide in relapsed ovarian cancer.
Int J Gynecol Cancer
; 31(7): 1037-1044, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34016703
3.
Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples.
BMC Med Res Methodol
; 20(1): 162, 2020 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32571298
4.
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
Lancet Oncol
; 15(9): 997-1006, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25035292
5.
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.
J Clin Oncol
; 41(1): 54-64, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960902
6.
Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial.
JAMA Oncol
; 9(5): 675-682, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36928279
7.
A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent Combinations.
Clin Cancer Res
; 28(17): 3639-3651, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552622
8.
Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE.
JCO Precis Oncol
; 6: e2200133, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36446040
9.
MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia.
BMJ Open
; 11(3): e046225, 2021 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33762245
10.
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases.
J Thorac Oncol
; 16(10): 1705-1717, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34116230
11.
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor.
Trials
; 21(1): 826, 2020 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33008427
12.
Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 935, 2020 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213530
13.
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Clin Transl Radiat Oncol
; 25: 61-66, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33072895
14.
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.
J Natl Cancer Inst
; 110(8): 871-879, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29425304
15.
Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer - An AZURE (BIG 01/04) sub-study.
J Bone Oncol
; 9: 48-54, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29234591
16.
Early phase clinical trials extension to guidelines for the content of statistical analysis plans.
BMJ
; 376: e068177, 2022 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131744
17.
Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.
Br J Radiol
; 89(1058): 20150628, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26760508
18.
The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma.
BMC Hematol
; 16: 14, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27190631
Resultados
1 -
18
de 18
1
Próxima >
>>